Metraipolis › archive › dc_bcf05ef89f9c
The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with… — Europe PMC PMID:42314073
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42314073
- DOI
- 10.1093/jleuko/qiag083
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T10:14:01.251Z
- SHA-256 of the archived text
db1ad178ec6d10c308b3da21cf548b9019ae2b517519ccfa15e67974091255bc- Stable URL of this page
https://metraipolis.com/documento/dc_bcf05ef89f9c
How to cite
The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with… — Europe PMC PMID:42314073 — Europe PMC (en), https://europepmc.org/article/MED/42314073 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcf05ef89f9c (Metraipolis archive dc_bcf05ef89f9c, sha256 db1ad178ec6d10c308b3da21cf548b9019ae2b517519ccfa15e67974091255bc)
BibTeX
@misc{dcbcf05ef89f9c,
title = {The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with… — Europe PMC PMID:42314073},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42314073},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcf05ef89f9c; sha256 db1ad178ec6d10c308b3da21cf548b9019ae2b517519ccfa15e67974091255bc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42314073. Agents can read the archived copy with the MCP tool read_document.